Stuart K. Roberts

18.2k total citations · 1 hit paper
242 papers, 6.6k citations indexed

About

Stuart K. Roberts is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Stuart K. Roberts has authored 242 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Epidemiology, 170 papers in Hepatology and 44 papers in Surgery. Recurrent topics in Stuart K. Roberts's work include Liver Disease Diagnosis and Treatment (140 papers), Hepatitis C virus research (96 papers) and Hepatitis B Virus Studies (65 papers). Stuart K. Roberts is often cited by papers focused on Liver Disease Diagnosis and Treatment (140 papers), Hepatitis C virus research (96 papers) and Hepatitis B Virus Studies (65 papers). Stuart K. Roberts collaborates with scholars based in Australia, United States and Germany. Stuart K. Roberts's co-authors include William Kemp, Matthew T. Kitson, TM Therneau, Wa Cheung, Kenneth R. Thomson, Peter Angus, Helen Kavnoudias, Adam Gordon, Ammar Majeed and Edward Gane and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Stuart K. Roberts

231 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Investigation of the Safety of Irreversible Electroporation in Humans

2011 355 citations Stuart K. Roberts et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart K. Roberts Australia	44	4.5k	4.3k	963	607	477	242	6.6k
Maurizio Pompili Italy	39	2.9k 0.7×	3.2k 0.7×	1.3k 1.3×	339 0.6×	247 0.5×	231	6.0k
Kyoji Moriya Japan	40	4.0k 0.9×	3.3k 0.8×	577 0.6×	820 1.4×	339 0.7×	218	7.3k
Marianne Ziol France	41	6.5k 1.4×	5.3k 1.2×	1.5k 1.6×	407 0.7×	452 0.9×	162	9.7k
Yogesh Chawla India	48	5.4k 1.2×	5.7k 1.3×	2.8k 2.9×	522 0.9×	768 1.6×	277	8.5k
Hans L. Tillmann Germany	53	6.4k 1.4×	6.3k 1.5×	528 0.5×	838 1.4×	265 0.6×	234	8.9k
Jay H. Lefkowitch United States	44	4.9k 1.1×	4.4k 1.0×	1.4k 1.4×	602 1.0×	523 1.1×	141	8.6k
Yi‐Hsiang Huang Taiwan	49	5.9k 1.3×	7.4k 1.7×	1.9k 2.0×	519 0.9×	370 0.8×	528	10.8k
Naoya Kato Japan	50	4.1k 0.9×	4.2k 1.0×	1.1k 1.1×	773 1.3×	171 0.4×	332	9.1k
Tsung‐Hui Hu Taiwan	45	4.3k 1.0×	4.4k 1.0×	1.4k 1.4×	465 0.8×	119 0.2×	339	7.4k
Rong‐Nan Chien Taiwan	39	8.7k 1.9×	8.3k 1.9×	571 0.6×	1.4k 2.3×	274 0.6×	247	9.9k

Countries citing papers authored by Stuart K. Roberts

Since Specialization

Citations

This map shows the geographic impact of Stuart K. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart K. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart K. Roberts more than expected).

Fields of papers citing papers by Stuart K. Roberts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart K. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart K. Roberts. The network helps show where Stuart K. Roberts may publish in the future.

Co-authorship network of co-authors of Stuart K. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart K. Roberts. A scholar is included among the top collaborators of Stuart K. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart K. Roberts. Stuart K. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nardo, William De, Olivia W. Lee, Jacqueline Bayliss, et al.. (2025). Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH. Cell Reports Medicine. 6(5). 102085–102085. 2 indexed citations

Tan, Sze‐Yen, et al.. (2025). Higher diet quality is associated with a lower prevalence of MASLD and adverse health outcomes: insights from NHANES 2005 to 2020. European Journal of Nutrition. 64(7). 289–289.

Howell, Jessica, Paula Binks, Paul J. Clark, et al.. (2024). Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action. The Medical Journal of Australia. 221(5). 230–235. 4 indexed citations

Kemp, William, Ammar Majeed, John Lubel, et al.. (2024). NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia. Hepatology International. 18(4). 1135–1143. 7 indexed citations

George, Elena S., Surbhi Sood, Riaz Uddin, Stuart K. Roberts, & Sheikh Mohammed Shariful Islam. (2024). The burden of non‐alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019. Internal Medicine Journal. 54(8). 1409–1413. 1 indexed citations

Read, Scott, et al.. (2024). Attitudes towards transjugular intrahepatic portosystemic shunt (TIPS) in Australia: a national survey of TIPS centres. BMJ Open Gastroenterology. 11(1). e001308–e001308. 2 indexed citations

Clayton‐Chubb, Daniel, William Kemp, Ammar Majeed, et al.. (2023). Metabolic dysfunction‐associated steatotic liver disease in older adults is associated with frailty and social disadvantage. Liver International. 44(1). 39–51. 28 indexed citations

Clark, Paul J., Patricia C. Valery, Simone I. Strasser, et al.. (2023). Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care. Journal of Gastroenterology and Hepatology. 39(3). 568–575. 2 indexed citations

Röder, Christine, Kathryn Mackie, Stuart K. Roberts, et al.. (2023). Leave No-One Behind: A Retrospective Study of Hepatitis C Testing and Linkage to Care for Hospital Inpatients. Viruses. 15(4). 913–913. 3 indexed citations

10.

Majeed, Ammar, Anouk Dev, Guy D. Eslick, et al.. (2022). Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Cancer. 54(2). 420–432. 14 indexed citations

11.

Ooi, Geraldine, Peter J. Meikle, Kevin Huynh, et al.. (2021). Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis. Journal of Hepatology. 75(3). 524–535. 83 indexed citations

12.

Gane, Edward, Hyung Joon Kim, Kumar Visvanathan, et al.. (2021). Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B. Hepatology. 74(4). 1737–1749. 30 indexed citations

13.

Sawhney, Rohit, Siddharth Sood, Anouk Dev, et al.. (2020). SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study). Journal of Gastrointestinal Cancer. 52(3). 907–914. 4 indexed citations

14.

Gow, Paul, Michael Fink, Anouk Dev, et al.. (2018). Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study. The Medical Journal of Australia. 209(8). 348–354. 43 indexed citations

15.

Ooi, Geraldine, Arul Earnest, William Kemp, et al.. (2018). Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. International Journal of Obesity. 42(11). 1900–1911. 22 indexed citations

16.

Gane, Edward, Hyung Joon Kim, Kumar Visvanathan, et al.. (2018). Safety, Pharmacokinetics and Pharmacodynamics of Oral TLR8 Agonist GS-9688 in Patients with Chronic Hepatitis B: A Randomized, Placebo-Controlled, Double-Blind Phase 1b Study. Hepatology. 68. 2 indexed citations

17.

Ooi, Geraldine, Guy D. Eslick, Paul R. Burton, et al.. (2017). Systematic review and meta‐analysis: non‐invasive detection of non‐alcoholic fatty liver disease related fibrosis in the obese. Obesity Reviews. 19(2). 281–294. 21 indexed citations

18.

Berg, Thomas, Pietro Andreoné, Stanislas Pol, et al.. (2014). Low‐density lipoprotein and other predictors of response with telaprevir‐based therapy in treatment‐experienced HCV genotype 1 patients: REALIZE study. Liver International. 35(2). 448–454. 5 indexed citations

19.

Zeuzem, Stefan, Vincent Soriano, Tarik Asselah, et al.. (2014). Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis. Antimicrobial Agents and Chemotherapy. 59(2). 1282–1291. 8 indexed citations

20.

Foster, Graham R., Stefan Zeuzem, Pietro Andreoné, et al.. (2011). 6 SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATION. Journal of Hepatology. 54. S3–S4. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact